{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:51:54Z","timestamp":1792032714272,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1053\/j.ajkd.2021.10.014","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:37:51Z","timestamp":1640947071000},"page":"108-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["CKD in Recipients of Nonkidney Solid Organ Transplants: A Review"],"prefix":"10.1053","volume":"80","author":[{"given":"Alexander C.","family":"Wiseman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.ajkd.2021.10.014_bib1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2021.10.014_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/ajt.15677","article-title":"OPTN\/SRTR 2018 annual data report: lung","volume":"20","author":"Valapour","year":"2020","journal-title":"Am J Transplant"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2021.10.014_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/ajt.15676","article-title":"OPTN\/SRTR 2018 annual data report: heart","volume":"20","author":"Colvin","year":"2020","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib4","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1111\/ajt.12257","article-title":"Predicting end-stage renal disease after liver transplant","volume":"13","author":"Israni","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2021.10.014_bib5","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.2215\/CJN.02950410","article-title":"An emerging population: kidney transplant candidates who are placed on the waiting list after liver, heart, and lung transplantation","volume":"5","author":"Srinivas","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/TP.0000000000000916","article-title":"Acute kidney disease after liver and heart transplantation","volume":"100","author":"Rossi","year":"2016","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2021.10.014_bib8","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1681\/ASN.V22s45","article-title":"Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury","volume":"2","author":"Myers","year":"1991","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1600-6143.2006.01302.x","article-title":"Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients","volume":"6","author":"Sis","year":"2006","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1046\/j.1523-1755.2000.00273.x","article-title":"Effect of nitric oxide modulation on TGF-beta1 and matrix proteins in chronic cyclosporine nephrotoxicity","volume":"58","author":"Shihab","year":"2000","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2021.10.014_bib11","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.healun.2018.07.022","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report\u20142018; focus theme: multiorgan transplantation","volume":"37","author":"Khush","year":"2018","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2021.10.014_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/TP.0000000000002023","article-title":"Influence of blood pressure and calcineurin inhibitors on kidney function after heart or liver transplantation","volume":"102","author":"Morath","year":"2018","journal-title":"Transplantation"},{"issue":"8","key":"10.1053\/j.ajkd.2021.10.014_bib13","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2215\/CJN.00650111","article-title":"Chronic kidney disease stage progression in liver transplant recipients","volume":"6","author":"Lamattina","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2021.10.014_bib14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.12659\/AOT.893788","article-title":"Risk factors for chronic renal insufficiency following cardiac transplantation","volume":"20","author":"Lachance","year":"2015","journal-title":"Ann Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/ajt.15706","article-title":"Blood pressure control according to clinical practice guidelines is associated with decreased mortality and cardiovascular events among liver transplant recipients","volume":"20","author":"VanWagner","year":"2020","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2021.10.014_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.28280","article-title":"Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis","volume":"63","author":"Lok","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1053\/j.ajkd.2021.10.014_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/liv.13498","article-title":"Spectrum of hepatitis B and renal involvement","volume":"38","author":"Shah","year":"2018","journal-title":"Liver Int"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1053\/j.gastro.2018.10.024","article-title":"Status of direct-acting antiviral therapy for hepatitis C virus infection and remaining challenges","volume":"156","author":"Baumert","year":"2019","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41581-018-0081-8","article-title":"Hepatitis C virus and the kidney","volume":"15","author":"Pol","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.trre.2015.02.004","article-title":"The prevalence and implications of BK virus replication in non-renal solid organ transplant recipients: a systematic review","volume":"29","author":"Viswesh","year":"2015","journal-title":"Transplant Rev"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib21","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1600-6143.2010.03224.x","article-title":"Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues","volume":"10","author":"Schwarz","year":"2010","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181c353e5","article-title":"The variable pathology of kidney disease after liver transplantation","volume":"89","author":"Kim","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.ajkd.2021.10.014_bib23","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1111\/j.1399-0012.2011.01542.x","article-title":"Renal histological lesions and outcome in liver transplant recipients","volume":"26","author":"Tsapenko","year":"2012","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.healun.2011.08.012","article-title":"Histopathology of renal failure after heart transplantation: a diverse spectrum","volume":"31","author":"Pinney","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1053\/j.ajkd.2014.01.436","article-title":"Performance of creatinine-based GFR estimating equations in solid-organ transplant recipients","volume":"63","author":"Shaffi","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib26","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1093\/ndt\/gfv338","article-title":"Measured and not estimated glomerular filtration rate should be used to assess renal function in heart transplant recipients","volume":"31","author":"Kolsrud","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2021.10.014_bib27","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-2277.2012.01449.x","article-title":"The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations","volume":"25","author":"Wagner","year":"2012","journal-title":"Transplant Int"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib28","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/TP.0000000000000552","article-title":"Serum cystatin C as an indicator of renal function and mortality in liver transplant recipients","volume":"99","author":"Allen","year":"2015","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/lt.20017","article-title":"Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations","volume":"10","author":"Gonwa","year":"2004","journal-title":"Liver Transplant"},{"issue":"7-8","key":"10.1053\/j.ajkd.2021.10.014_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.clinbiochem.2017.01.008","article-title":"Predictive performance of different kidney function estimation equations in lung transplant patients","volume":"50","author":"Degen","year":"2017","journal-title":"Clin Biochem"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s11255-020-02432-y","article-title":"Kidney biopsy in patients after liver transplantation: an underutilized, but clinically important procedure","volume":"52","author":"Wieliczko","year":"2020","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive summary of the KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2021.10.014_bib33","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.kint.2020.06.024","article-title":"Executive summary of the 2020 KDIGO diabetes management in CKD guideline: evidence-based advances in monitoring and treatment","volume":"98","author":"De Boer","year":"2020","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib34","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2021.10.014_bib35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib36","first-page":"989","article-title":"Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study","volume":"32","author":"Di Iorio","year":"2019","journal-title":"J\u00a0Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib37","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1681\/ASN.2016070793","article-title":"Metabolic acidosis and long-term clinical outcomes in kidney transplant recipients","volume":"28","author":"Park","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib38","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/ajt.13765","article-title":"Protecting the kidney in liver transplant recipients: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice","volume":"16","author":"Levitsky","year":"2016","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib39","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/ki.2010.388","article-title":"Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans","volume":"79","author":"Raphael","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib40","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1097\/TP.0000000000000555","article-title":"Three-year outcomes in de novo liver transplant patients receiving everolimus with reduced tacrolimus: follow-up results from a randomized, multicenter study","volume":"99","author":"Fischer","year":"2015","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/lt.23658","article-title":"Calcineurin inhibitor-free mycophenolate mofetil\/sirolimus maintenance in liver transplantation: the Randomized Spare-The-Nephron Trial","volume":"19","author":"Teperman","year":"2013","journal-title":"Liver Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib42","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1600-6143.2011.03919.x","article-title":"Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial","volume":"12","author":"Abdelmalek","year":"2012","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2021.10.014_bib43","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/lt.21827","article-title":"Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial","volume":"15","author":"De Simone","year":"2009","journal-title":"Liver Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib44","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.transproceed.2009.06.152","article-title":"Combined mycophenolate mofetil and minimal dose calcineurin inhibitor therapy in liver transplant patients: clinical results of a prospective randomized study","volume":"41","author":"Beckebaum","year":"2009","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1053\/j.ajkd.2021.10.014_bib45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/TP.0000000000002702","article-title":"Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: long-term follow-up from the randomized SCHEDULE Study","volume":"104","author":"Gustafsson","year":"2020","journal-title":"Transplantation"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib46","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/ajt.16155","article-title":"Effects of mTOR inhibitor-related proteinuria on progression of cardiac allograft vasculopathy and outcomes among heart transplant recipients","volume":"21","author":"Asleh","year":"2021","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib47","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1111\/ajt.12833","article-title":"Sirolimus conversion after heart transplant: risk factors for acute rejection and predictors of renal function response","volume":"14","author":"Zuckermann","year":"2014","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib48","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tri.12783","article-title":"Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial","volume":"29","author":"Gullestad","year":"2016","journal-title":"Transplant Int"},{"issue":"1","key":"10.1053\/j.ajkd.2021.10.014_bib49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.healun.2014.06.001","article-title":"Three-year results of an investigator-driven multicenter, international, randomized open-label de novo trial to prevent BOS after lung transplantation","volume":"34","author":"Glanville","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0000000000001006","article-title":"Conversion from calcineurin to mammalian target of rapamycin inhibitors in liver transplantation: a meta-analysis of randomized controlled trials","volume":"100","author":"Glover","year":"2016","journal-title":"Transplantation"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib51","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency","volume":"12","author":"Zuckermann","year":"2012","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2021.10.014_bib52","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/j.1600-6143.2012.04157.x","article-title":"Calcineurin inhibitor sparing with mycophenolate mofetil in liver transplantion: a systematic review of randomized controlled trials","volume":"12","author":"Goralczyk","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2021.10.014_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.trre.2007.12.001","article-title":"mToR inhibitors-induced proteinuria: mechanisms, significance, and management","volume":"22","author":"Letavernier","year":"2008","journal-title":"Transplant Rev"},{"issue":"5","key":"10.1053\/j.ajkd.2021.10.014_bib54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1681\/ASN.V1251059","article-title":"Pharmacokinetic interactions augment toxicities of sirolimus\/cyclosporine combinations","volume":"12","author":"Podder","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A\u00a0phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2021.10.014_bib56","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2021.10.014_bib57","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/ajt.12810","article-title":"Belatacept-based immunosuppression in de novo liver transplant recipients:1-year experience from a phase II randomized study","volume":"14","author":"Klintmalm","year":"2014","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib58","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000002291","article-title":"Belatacept in solid organ transplant: review of current\u00a0literature across transplant types","volume":"102","author":"Perez","year":"2018","journal-title":"Transplantation"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s40472-018-0199-4","article-title":"Immunosuppression for lung transplantation: current and future","volume":"5","author":"Chandrashekaran","year":"2018","journal-title":"Curr Transplant Rep"},{"issue":"11","key":"10.1053\/j.ajkd.2021.10.014_bib60","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1111\/j.1600-6143.2010.03292.x","article-title":"Wait list death and survival benefit of kidney transplantation among nonrenal transplant recipients","volume":"10","author":"Cassuto","year":"2010","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib61","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1600-6143.2008.02540.x","article-title":"Kidney transplantation in previous heart or lung recipients","volume":"9","author":"Lonze","year":"2009","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2021.10.014_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13108","article-title":"Outcome of kidney transplant in primary, repeat, and kidney-after-nonrenal solid-organ transplantation:15-year analysis of recent UNOS database","volume":"31","author":"El-Husseini","year":"2017","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2021.10.014_bib63","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1097\/TP.0000000000002596","article-title":"Outcomes in older kidney transplant recipients after prior nonkidney transplants","volume":"103","author":"Haugen","year":"2019","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ajkd.2021.10.014_bib64","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12953","article-title":"Long-term survival following kidney transplantation in previous lung transplant recipients: an analysis of the UNOS registry","volume":"31","author":"Osho","year":"2017","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2021.10.014_bib65","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s10620-019-05858-2","article-title":"Limited progress in hepatorenal syndrome (HRS) reversal and survival 2002-2018: a systematic review and meta-analysis","volume":"65","author":"Thomson","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1053\/j.ajkd.2021.10.014_bib66","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/TP.0000000000000215","article-title":"Renal outcomes of liver transplant recipients who had pretransplant kidney biopsy","volume":"98","author":"Wadei","year":"2014","journal-title":"Transplantation"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib67","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/TP.0b013e3181cd4abb","article-title":"The role of kidney biopsy in heart transplant candidates with kidney disease","volume":"89","author":"Labban","year":"2010","journal-title":"Transplantation"},{"issue":"11","key":"10.1053\/j.ajkd.2021.10.014_bib69","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1111\/ajt.16761","article-title":"Developing simultaneous liver-kidney transplant medical eligibility criteria while providing a safety net: a 2-year review of the OPTN\u2019s allocation policy","volume":"21","author":"Wilk","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.ajkd.2021.10.014_bib70","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/ajt.13631","article-title":"Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources","volume":"16","author":"Formica","year":"2016","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2021.10.014_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/cld.609","article-title":"Changes in United Network for Organ Sharing policy for simultaneous liver-kidney allocation","volume":"9","author":"Merola","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2021.10.014_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13878","article-title":"To kidney or not to kidney: applying lessons learned from the simultaneous liver-kidney transplant policy to simultaneous heart-kidney transplantation","volume":"34","author":"Cheng","year":"2020","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib73","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/ajt.16512","article-title":"Consensus Conference Participants. Consensus conference on heart-kidney transplantation","volume":"21","author":"Kobashigawa","year":"2021","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2021.10.014_bib74","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1681\/ASN.2013040436","article-title":"Patient-specific prediction of ESRD after liver transplantation","volume":"24","author":"Sharma","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib75","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/lt.25302","article-title":"Knowledge of chronic kidney disease among liver transplant recipients","volume":"24","author":"Park","year":"2018","journal-title":"Liver Transplant"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219856","article-title":"Novel educational and goal-setting tool to improve knowledge of chronic kidney disease among liver transplant recipients: a pilot study","volume":"14","author":"Leek","year":"2019","journal-title":"PloS One"},{"issue":"7","key":"10.1053\/j.ajkd.2021.10.014_bib77","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/TP.0000000000002175","article-title":"Cardiovascular disease outcomes related to early stage renal impairment after liver transplantation","volume":"102","author":"VanWagner","year":"2018","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ajkd.2021.10.014_bib78","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/TP.0000000000002075","article-title":"Early postoperative neutrophil gelatinase-associated lipocalin predicts the development of chronic kidney disease after liver transplantation","volume":"102","author":"Cullaro","year":"2018","journal-title":"Transplantation"},{"issue":"12","key":"10.1053\/j.ajkd.2021.10.014_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13415","article-title":"Delayed calcineurin inhibitor introduction and renal outcomes in liver transplant recipients receiving basiliximab induction","volume":"32","author":"Lange","year":"2018","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2021.10.014_bib80","article-title":"Renal outcomes of liver transplantation recipients receiving standard immunosuppression and early renal sparing immunosuppression: a retrospective single center study","volume":"5","author":"Sharma","year":"2019","journal-title":"Transplant Direct"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621010477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638621010477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:43:01Z","timestamp":1759462981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638621010477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0272638621010477"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.10.014","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CKD in Recipients of Nonkidney Solid Organ Transplants: A Review","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2021.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}